Lakeland PeptidesPeptide therapy, explained · Lakeland & Polk County, FL

Peptide library

GHRP-6: What Lakeland Readers Should Know

Also known as: Growth hormone-releasing peptide-6, GHRP6, SKF-110679

Not reviewed by a licensed provider. Read our disclaimer

Last updated

At a glance

Type
Growth hormone-releasing peptide (ghrelin-receptor agonist)
Human evidence
Very limited human data Only small or early human studies exist.
FDA status
Not FDA-approved anywhere in the sources reviewed; on FDA's 503B safety-risk list and in 503A Category 3 (as of May 14, 2026)
How it is given
Injection in published studies; one study used an oral form

GHRP-6 was the first of the ghrelin-copying peptides studied in people, and the others came from it. It does raise growth hormone, but no controlled trial has tested it for any treatment goal. This page explains what is known. It is general information, not advice for your situation.

What it is and how it works

GHRP-6 is a lab-made chain of six amino acids. It acts on the receptor for ghrelin, the hormone best known for signaling hunger. Switching that receptor on in the brain and pituitary gland makes the pituitary release the body’s own growth hormone.1 Later peptides such as ipamorelin and GHRP-2 were developed from this starting point.2

Unlike sermorelin and other GHRH analogs, GHRP-6 also raises the stress hormone cortisol.3

What the research shows (and where evidence is weak)

It raises growth hormone. In 9 healthy young men, a 34-hour drip of GHRP-6 roughly doubled total growth hormone output. It did this by making natural pulses larger, not more frequent, and IGF-1 (a growth-related hormone) rose modestly. The pituitary stayed responsive over that day and a half.4 In 13 children with short stature, an oral form produced a growth hormone peak similar to an injected dose of GHRH.5

It also raises cortisol and changes sleep. In healthy men, overnight dosing raised growth hormone, ACTH and cortisol compared with placebo. It increased lighter stage 2 sleep while leaving deep slow-wave sleep unchanged. The cortisol effect is the opposite of what GHRH does.3

It clears quickly. In 9 healthy men, the elimination half-life after an injection into a vein was about 2.5 hours.6

It makes people hungry. A consistent appetite-stimulating effect is described as characteristic of GHRP-6. The measured human food-intake data come from its relative GHRP-2, not from GHRP-6 itself.17

Key gaps. No controlled trial has tested GHRP-6 for muscle, fat loss, strength, recovery, injury or aging, in healthy adults or anyone else. A 2026 review places the whole group at the level of early-phase and small mechanism studies, with no controlled effectiveness trials and no long-term safety data.1 Heart-protective findings come from animal and laboratory models only.1

Where growth hormone itself was tested in healthy older adults, a review of randomized trials found about 2 kg less fat and 2 kg more lean mass, no weight change, no change in bone density, and significantly more swelling, joint pain, carpal tunnel syndrome and breast tissue growth in men. The reviewers concluded growth hormone cannot be recommended as an anti-aging therapy.8

FDA and regulatory status

Not approved. There is no FDA-approved GHRP-6 product, and no approval in another country was identified in the sources reviewed.9

Compounding. As of FDA’s page dated April 22, 2026, GHRP-6 is on FDA’s significant-safety-risk list (Category 2) for outsourcing facilities (503B), added September 29, 2023.9 On FDA’s 503A list updated May 14, 2026, it is in Category 3, “nominated without adequate support.”10 FDA’s stated concerns are immune reactions from clumping and impurities, a possible effect on cortisol, and a rise in blood sugar from reduced insulin sensitivity.9 Florida pharmacy and prescribing rules also apply; see are peptides legal in Florida?. See compounded vs. FDA-approved peptides.

“Research chemical” products. GHRP-6 is widely sold online labeled “not for human use.” These products are not made to drug-quality standards. See research-chemical peptide risks.

Sport. The World Anti-Doping Agency’s 2026 Prohibited List names GHRP-6 among growth hormone-releasing peptides that are banned at all times.11

Common side effects and safety

  • Raised cortisol and ACTH in healthy people. This is documented, not theoretical, and it can confuse hormone testing.3
  • Changed sleep structure, with more light sleep and no gain in deep sleep.3
  • More appetite, a known effect of ghrelin-copying peptides.1
  • FDA’s concerns: immune reactions from compounded products, a possible effect on cortisol, and higher blood sugar from reduced insulin sensitivity. FDA says safety information is limited.9
  • No long-term safety data exist for GHRP-6 in any group.1

Because growth hormone products carry warnings about tumor risk, blood sugar and fluid retention, researchers treat those as open questions for this group of peptides. No cancer signal has been established for GHRP-6.1

Tell a licensed provider about any symptom that worries you.

Typical cost range

There is no approved product, so there is no official price. Insurance does not cover unapproved drugs. Ask any provider for a written price breakdown before you start. See our cost guide.

Questions to ask a provider

  • GHRP-6 is not FDA-approved. Where does your product come from, and how is that allowed?
  • What human evidence supports it for my goal, given that no controlled trial has tested one?
  • It raises cortisol and appetite. How will you monitor for that?
  • What lab work, such as blood sugar and cortisol, will you check before and during use?
  • Are there FDA-approved or better-studied options? See how to vet a peptide clinic.

Footnotes

  1. Dominikowski A, Rękoś Z, Olejarz M, et al. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration. Front Endocrinol (Lausanne). 2026;17:1822475. doi:10.3389/fendo.2026.1822475. https://doi.org/10.3389/fendo.2026.1822475 ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7

  2. Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-561. doi:10.1530/eje.0.1390552. https://doi.org/10.1530/eje.0.1390552 ↩

  3. Frieboes RM, Murck H, Maier P, et al. Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man. Neuroendocrinology. 1995;61(5):584-589. doi:10.1159/000126883. https://doi.org/10.1159/000126883 ↩ ↩2 ↩3 ↩4

  4. Jaffe CA, Ho PJ, Demott-Friberg R, Bowers CY, Barkan AL. Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men. J Clin Endocrinol Metab. 1993;77(6):1641-1647. doi:10.1210/jcem.77.6.7903313. https://doi.org/10.1210/jcem.77.6.7903313 ↩

  5. Bellone J, Ghizzoni L, Aimaretti G, et al. Growth hormone-releasing effect of oral growth hormone-releasing peptide 6 (GHRP-6) administration in children with short stature. Eur J Endocrinol. 1995;133(4):425-429. doi:10.1530/eje.0.1330425. https://doi.org/10.1530/eje.0.1330425 ↩

  6. Cabrales A, Gil J, Fernández E, et al. Pharmacokinetic study of growth hormone-releasing peptide 6 (GHRP-6) in nine male healthy volunteers. Eur J Pharm Sci. 2013;48(1-2):40-46. doi:10.1016/j.ejps.2012.10.006. https://doi.org/10.1016/j.ejps.2012.10.006 ↩

  7. Laferrère B, Abraham C, Russell CD, Bowers CY. Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men. J Clin Endocrinol Metab. 2005;90(2):611-614. doi:10.1210/jc.2004-1719. https://doi.org/10.1210/jc.2004-1719 ↩

  8. Liu H, Bravata DM, Olkin I, et al. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med. 2007;146(2):104-115. doi:10.7326/0003-4819-146-2-200701160-00005. https://doi.org/10.7326/0003-4819-146-2-200701160-00005 ↩

  9. U.S. Food and Drug Administration. Certain bulk drug substances for use in compounding that may present significant safety risks. Content current April 22, 2026. Accessed November 2026. https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks ↩ ↩2 ↩3 ↩4

  10. U.S. Food and Drug Administration. Bulk drug substances nominated for use in compounding under section 503A of the FD&C Act. Updated May 14, 2026. Accessed November 2026. https://www.fda.gov/media/94155/download ↩

  11. World Anti-Doping Agency. The Prohibited List (2026). Accessed November 2026. https://www.wada-ama.org/en/prohibited-list ↩

Frequently asked questions

Is GHRP-6 FDA-approved?

No. There is no FDA-approved GHRP-6 product, and no approval in another country was found in the sources reviewed.

Does GHRP-6 raise growth hormone?

Yes. In small studies it reliably raised growth hormone by making the body's natural pulses bigger, not more frequent. That is a hormone change, not a proven health benefit.

What are the main downsides?

It also raises the stress hormone cortisol and ACTH, changes sleep stages, and increases appetite. FDA also cites a possible rise in blood sugar from reduced insulin sensitivity.

Is GHRP-6 good for the heart?

Heart-protective findings for GHRP-6 come from animal and laboratory studies only. They have not been confirmed in people.

Can athletes use GHRP-6?

No. The World Anti-Doping Agency names GHRP-6 on its 2026 Prohibited List, banned at all times.

Questions? Talk to a licensed provider

See a free list of top rated clinics in Lakeland and Polk County, with their phone numbers and Google reviews. No one will call you.

Find a top rated provider
Find a top rated provider today